Elesclomol, a copper chelator, suppresses CRC both in vitro and in vivo by inducing ROS accumulation and is associated with downregulation of SLC7A11 protein levels via ubiquitination and degradation (122). This evidence concerns the gene SLC7A11 and colorectal carcinoma.